U.S. Research Roundup-Everpure, Marvell Technology, Okta

| | | --- | | * Abercrombie & Fitch Co. ANF.N: JP Morgan raises target price to $126 from $110 | | * Everpure Inc P.N: TD Cowen raises target price to $170 from $100 | | * Marvell Technology, Inc. MRVL.O: TD Cowen raises target price to $225 from $200 | | * Okta Inc OKTA.O: Jefferies raises target price to $170 from $140 | | * Urban Outfitters Inc URBN.O: JP Morgan raises target price to $110 from $97 | | | | --- | | * Abercrombie & Fitch Co. ANF.N: JP Morgan raises target price to $126 from $110 | | * Abercrombie & Fitch Co. ANF.N: Raymond James cuts to market perform from outperform | | * Acadia Realty Trust AKR.N: KeyBanc raises to overweight from sector weight | | * Amgen Inc AMGN.O: Mizuho raises target price to $352 from $303 | | * Applied Materials Inc AMAT.O: Argus Research raises target price to $600 from $500 | | * Ataibeckley Inc ATAI.O: Oppenheimer cuts to perform from outperform | | * Bath & Body Works, Inc. BBWI.N: Citigroup raises to buy from neutral | | * Biomarin Pharmaceutical Inc. BMRN.O: H.C. Wainwright cuts target price to $59 from $60 | | * Campbell'S Co CPB.O: JP Morgan raises target price to $22 from $20 | | * Cheniere Energy Inc LNG.N: Argus Research raises target price to $330 from $284 | | * Chime Financial Inc CHYM.O: Morgan Stanley raises target price to $39.00 from $33.00 | | * Choice Hotels International Inc CHH.N: Morgan Stanley raises target to $91.00 from $86.00 | | * Ciena Corporation CIEN.N: TD Cowen cuts target price to $575 from $675 | | * Corcept Therapeutics Incorporated CORT.O: Truist Securities assumes with buy rating | | * Corcept Therapeutics Incorporated CORT.O: Truist Securities assumes with PT $164 vs $50 | | * Corteva, Inc. CTVA.N: UBS cuts target price to $85 from $89 | | * Crowdstrike CRWD.O: Benchmark raises target price to $250 from $230 | | * Diamondrock Hospitality Co DRH.O: Morgan Stanley raises target price to $11.00 from $10.00 | | * Duolingo, Inc. DUOL.O: D.A. Davidson raises to buy from neutral; raises PT to $160 | | * Enliven Therapeutics, Inc. ELVN.O: Mizuho raises target price to $73 from $62 | | * Enliven Therapeutics, Inc. ELVN.O: William Blair initiates coverage with outperform rating | | * Essex Property Trust ESS.N: Deutsche Bank cuts target price to $325 from $330 | | * Ethos Technologies Inc LIFE.O: JP Morgan raises target price to $37 from $23 | | * Everpure Inc P.N: TD Cowen raises target price to $170 from $100 | | * Eyepoint Inc EYPT.O: Citigroup cuts target price to $17 from $35 | | * Eyepoint Inc EYPT.O: H.C. Wainwright cuts to neutral from buy | | * Eyepoint Inc EYPT.O: Jefferies cuts target price to $8 from $30 | | * Eyepoint Inc EYPT.O: JP Morgan cuts to neutral from overweight | | * Eyepoint Inc EYPT.O: RBC cuts to sector perform from outperform; cuts PT to $5 from $37 | | * Ferguson Enterprises FERG.N: BofA Global Research cuts price objective to $315 from $325 | | * Ferguson Enterprises Inc FERG.N: Deutsche Bank raises target price to $261 from $256 | | * First Solar Inc FSLR.O: Morgan Stanley raises target price to $323.00 from $245.00 | | * First Tracks Biotherapeutics Inc TRAX.O: JP Morgan raises target price to $65 from $30 | | * Flutter Entertainment Plc FLUT.N: Goldman Sachs cuts target price to $162 from $190 | | * Freenome, Inc. FRNM.O: TD Cowen initiates coverage with buy rating; price target $17 | | * Gartner IT.N: BMO cuts target price to $206 from $214 | | * Haemonetics Corp HAE.N: BofA Global Research raises price objective to $120 from $100 | | * Haemonetics Corp HAE.N: BTIG raises target price to $110 from $96 | | * Hilton Grand Vacations Inc HGV.N: Morgan Stanley cuts target price to $54.00 from $58.00 | | * Hyatt Hotels Corporation H.N: Morgan Stanley cuts target price to $209.00 from $218.00 | | * Inc WH.N: Morgan Stanley cuts target price to $91.00 from $93.00 | | * Kite Realty Group Trust KRG.N: KeyBanc cuts to sector weight from overweight | | * L3Harris Technologies, Inc. LHX.N: Deutsche Bank cuts target price to $269 from $285 | | * Lantheus Holdings, Inc. LNTH.O: B. Riley cuts target price to $105.4 from $129 | | * Lantheus Holdings, Inc. LNTH.O: B. Riley cuts to neutral from buy | | * Life Time Group Holdings, Inc LTH.N: Morgan Stanley raises target price to $53 from $39 | | * Marriott Vacations Worldwide Corp VAC.N: Morgan Stanley raises target to $65 from $52 | | * Marvell Technology, Inc. MRVL.O: TD Cowen raises target price to $225 from $200 | | * Mongodb, Inc. MDB.O: Stifel raises target price to $475 from $435 | | * NetApp Inc NTAP.O: Citigroup raises target price to $209 from $150 | | * Norwegian Cruise Line NCLH.N: Mizuho cuts target price to $17 from $22 | | * Norwegian Cruise Line NCLH.N: Mizuho cuts to neutral from outperform | | * Norwegian Cruise Line Holdings Ltd NCLH.N: UBS raises target price to $20 from $17 | | * Nuvation Bio Inc. NUVB.N: JP Morgan initiates coverage with overweight rating; PT $13 | | * Okta, Inc. OKTA.O: Jefferies raises target price to $170 from $140 | | * Quince Therapeutics QNCX.O: Leerink Partners adjusts PT to $68 from $4 to reflect 1-for-20 reverse stock split | | * Sailpoint Inc SAIL.O: BofA Global Research raises price objective to $19 from $16 | | * Salesforce, Inc. CRM.N: Citigroup raises target price to $204 from $187 | | * Scribe Therapeutics Inc SCTX.O: Leerink Partners initiates with outperform rating | | * Scribe Therapeutics Inc SCTX.O: Leerink Partners initiates with price target $37 | | * Sentinelone Inc S.N: BofA Global Research raises price objective to $26 from $22 | | * Sharplink SBET.O: Canaccord Genuity cuts target price to $8 from $16 | | * Smartfinancial Inc SMBK.N: Benchmark raises target price to $60 from $56 | | * Snowflake Inc. SNOW.N: Stifel raises target price to $350 from $300 | | * Snowflake Inc SNOW.N: UBS raises target price to $425 from $370 | | * Sunshine Silver Mining & Refining Co SSMR.N: Canaccord Genuity initiates with PT $20 | | * Sunshine Silver Mining & Refining Co SSMR.N: Canaccord Genuity initiates with speculative buy rating | | * Tango Therapeutics Inc TNGX.O: H.C. Wainwright raises target price to $68 from $66 | | * Targa Resources Corp TRGP.N: Jefferies raises target price to $345 from $324 | | * Target Hospitality Corp TH.O: Morgan Stanley initiates coverage with overweight rating | | * Target Hospitality Corp TH.O: Morgan Stanley initiates coverage with price target $22 | | * The New York Times Company NYT.N: Deutsche Bank cuts target price to $75 from $95 | | * Travel & Leisure Co TNL.N: Morgan Stanley raises target price to $85.00 from $83.00 | | * Urban Outfitters Inc URBN.O: JP Morgan raises target price to $110 from $97 | | * Victoria'S Secret & Co VSXY.N: UBS raises target price to $95 from $90 | | * Waterbridge Infrastructure Llc WBI.N: JP Morgan resumes coverage with overweight rating | | * Waterbridge Infrastructure Llc WBI.N: JP Morgan resumes coverage with target price $38 | | * Weave Communications Inc WEAV.N: B. Riley initiates coverage with buy rating; PT $8.25 | | * Weave Communications Inc WEAV.N: Piper Sandler cuts to neutral from overweight | | * Weave Communications Inc WEAV.N: Piper Sandler cuts target price to $7.4 from $8 | | * Xerox Holdings Corp XRX.O: Northland Capital initiates coverage with outperform rating | | * Xerox Holdings Corp XRX.O: Northland Capital initiates coverage with target price $5 | | * York Space Systems Inc YSS.N: Canaccord Genuity cuts target price to $13.5 from $36 | | * York Space Systems Inc YSS.N: Canaccord Genuity cuts to hold from buy | | * York Space Systems Inc YSS.N: Jefferies cuts target price to $15 from $32 | | * Zscaler Inc ZS.O: BofA Global Research raises price objective to $210 from $175 Aug. 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Everpure, Marvell Technology and Okta, on Tuesday. Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

U.S. Research Roundup-Everpure, Marvell Technology, Okta

Highlights and research actions

Wall Street analysts revise ratings and targets

Related News

EHang schedules Q2 unaudited results release, earnings call

Auto File-US automakers try to avoid Mexico-Canada trade pothole

Amylyx Pharmaceuticals, Inc. <AMLX.O>: H.C. Wainwright Raises Target Price to $55 From $34

Amylyx soars as blood sugar drug succeeds in late-stage trial

Valero publishes 2025 ESG report